My take on the $300mil is this is current cost to industry + revenue from recovered products, rather than Parkway turnover from their IP being deployed. So if turnover for the treatment was 100% of this and we are otherwise looking at 10%, then 5% + upfront is $15 X 3-5 (under those calcs), so $45-$75 Mil. I also like this as it would well capitalise Parkway for other endeavours, whilst not giving away all revenue streams.
My take on the $300mil is this is current cost to industry +...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PWN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.67M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $50.38K | 5.082M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 6572648 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 145529 | 1 |
View Market Depth
| Last trade - 15.11pm 11/09/2024 (20 minute delay) ? |
| PWN (ASX) Chart |